Download PDF
Arzneimittelforschung 2009; 59(8): 383-391
DOI: 10.1055/s-0031-1296412
Antihypertensives
Editio Cantor Verlag Aulendorf (Germany)

Liquid Chromatography–Mass Spectrometry Method for the Determination of Amlodipine in Human Plasma and its Application in a Bioequivalence Study

Qiaogen Zou
1   College of Life Science and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing, (PR China)
2   Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, (PR China)
,
Ying Zhan
2   Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, (PR China)
,
Zhengxiang Ge
1   College of Life Science and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing, (PR China)
,
Ping Wei
1   College of Life Science and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing, (PR China)
,
Pingkai Ouyang
1   College of Life Science and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing, (PR China)
› Author Affiliations
Further Information

Publication History

Publication Date:
13 December 2011 (online)

    Permissions and Reprints

Abstract

A sensitive and selective liquid chromatographic-mass spectrometric (LC-MS) method for the determination of amlodipine (CAS 88150-42-9) in human plasma has been developed. Sample preparation was based on liquid-liquid extraction using NaOH and cyclohexane. Analytical determination was carried out on a C18 column interfaced with a single quadrupole mass spectrometer. Positive electrospray ionization was employed as the ionization source. The mobile phase was 10 mmol/L ammonium acetate solution-methanol (30 : 70, v/v) at the flow rate of 0.2 mL/min. The method was linear in the concentration range of 0.2–20 ng/mL. The lower limit of quantification was 0.2 ng/mL. Amlodipine was sensitive to UV light. The method was validated in terms of accuracy, precision, absolute recovery, and stability. The intra- and inter-day relative standard deviation across three validation runs over the entire concentration range was less than 8.17%. The accuracy determined at three concentrations (0.4, 2.0 and 10 ng/mL for amlodipine maleate) was within ± 3.17% in terms of relative error. The method herein described was successfully applied for the evaluation of pharmacokinetic profiles of amlodipine maleate tablets in 20 healthy volunteers. The results showed that AUC, Tmax, Cmax and T1/2 between the test and reference formulation have no significant difference (P > 0.05). The relative bioavailability was 103.7 ± 12.3%.

Key words

Amlodipine maleate, liquid chromatographic-mass spectrometric determination, pharmacokinetics - Calcium antagonists - CAS 88150-42-9
 

  • References

  • 1 Arrowsmith JE, Campbell SF, Cross PE, Stubbs JK, Burges RA, Gardiner DG, Blackburn KL. Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. J Med Chem. 1986; 29: 1696-702
    CrossrefPubMedGoogle Scholar
  • 2 Burges R, Moisey D. Unique pharmacologic properties of amlodipine. Am J Cardiol. 1994; 73: 2A-9A
    CrossrefPubMedGoogle Scholar
  • 3 Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 1992; 22: 22-31
    CrossrefPubMedGoogle Scholar
  • 4 EMEA/CPMC opinion following an article 29 referral. International non-proprietary name: Amlodipine. London; 2004.
    PubMed
  • 5 Park JY, Kim KA, Lee GS, Park PW, Kim SL, Lee YS et al. Randomized, openlabel, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects. Clin Ther. 2004; 26: 715-23
    CrossrefPubMedGoogle Scholar
  • 6 Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kyun J et al. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, eight-week follow-up, noninferiority trial. Clin Ther. 2006; 28: 537-55
    CrossrefPubMedGoogle Scholar
  • 7 Zhang H, Wang SM. Comparative study of amlodipine maleate and amlodipine benzene sulfonate on hypertension. Modern Med Health. 2004; 16: 1648-9
    PubMedGoogle Scholar
  • 8 Stopher DA, Beresford AP, Macrae PV, Humphrey MJ. The metabolism and pharmacokinetics of amlodipine in human and animals. J Cardiovasc Pharmacol. 1988; 12: S55-9
    PubMedGoogle Scholar
  • 9 Murdoch D, Heel RC. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs. 1991; 41: 478-505
    CrossrefPubMedGoogle Scholar
  • 10 Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies. Il Farmaco. 2005; 60: 789-92
    CrossrefPubMedGoogle Scholar
  • 11 Bahrami GH, Mirzaeei SH. Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies. J Pharm Biomed Anal. 2004; 36: 163-8
    CrossrefPubMedGoogle Scholar
  • 12 Josefsson M, Zackrisson AL, Norlander B. Sensitive high-performance liquid chromatographic analysis of amlodipine in human plasma with amperometric detection and a single step solid-phase sample preparation. J Chromatogr B Biomed Appl. 1995; 672: 310-3
    CrossrefPubMedGoogle Scholar
  • 13 Monkman SC, Ellis JS, Cholerton S, Thomason JM, Seymour RA, Idle JR. Automated gas chromatographic assay for amlodipine in plasma and gingival crevicular fluid. J Chromatogr B Biomed Appl. 1996; 678: 360-4
    CrossrefPubMedGoogle Scholar
  • 14 Suchanova B, Kostiainen R, Setola RA. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography–mass spectrometry. Eur J Pharm Sci. 2008; 33: 91-9
    CrossrefPubMedGoogle Scholar
  • 15 Carvalho M, Oliveira CH, Mendes GD, Sucupira M, Moraes ME, De Nucci G. Amlodipine bioequivalence study: quantification by liquid chromatography coupled to tandem mass spectrometry. Biopharm Drug Dispos. 2001; 22: 383-90
    CrossrefPubMedGoogle Scholar
  • 16 Abad-Santos F, Novalbos J, Gálvez-Múgica MA, Gallego-Sandín S, Almeida S, Vallée F, García AG. Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study. Pharmacol Res. 2005; 51: 445-52
    CrossrefPubMedGoogle Scholar
  • 17 Massaroti P, Moraes LAB, Marchioretto MAM, Cassiano NM, Bernasconi G, Calafatti SA et al. Development and validation of a selective and robust LC-MS/MS method for quantifying amlodipine in human plasma. Anal Bioanal Chem. 2005; 382: 1049-54
    CrossrefPubMedGoogle Scholar
  • 18 Nirogi RVS, Kandikere VN, Mudigonda K, Shukla M, Maurya S. Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma. Biomed. Chromatogr. 2006; 20: 833-42
    CrossrefPubMedGoogle Scholar
  • 19 Bhatt J, Singh S, Subbaiah G, Shah B, Kambli S, Ameta S. A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of amlodipine in human plasma. Biomed Chromatogr. 2007; 21: 169-75
    CrossrefPubMedGoogle Scholar
  • 20 Yuanyuan Ma, Feng Qin, Xiaohong Sun, Xiumei Lu, Famei Li. Determination and pharmacokinetic study of amlodipine in humanplasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry. J Pharm Biomed Anal. 2007; 43: 1540-5
    CrossrefPubMedGoogle Scholar
  • 21 Mignini F, Tomassoni D, Traini E, Amenta F. Single-Dose, Randomized, Crossover Bioequivalence Study of Amlodipine Maleate versus Amlodipine Besylate in Healthy Volunteers. Clin Exp Hypertens. 2007; 29: 539-52
    CrossrefPubMedGoogle Scholar
  • 22 Ragno G, Cione E, Garofalo A, Genchi G, Ioele G, Risoli A et al. Design and monitoring of photostability systems for amlodipine dosage forms. Int J Pharm. 2003; 265: 125-32
    CrossrefPubMedGoogle Scholar
  • 23 Naidu KR, Kale UN, Shingare MS. Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benezepril hydrochloride from their combination drug product. J Pharm Biomed Anal. 2005; 39: 147-55
    CrossrefPubMedGoogle Scholar
  • 24 Chaudhari BG, Patel NM, Shah PB. Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chem Pharm Bull. 2007; 55: 241-6
    CrossrefPubMedGoogle Scholar